According to the research report titled ‘North America Autoimmune Disease Diagnostics Market Value By Product, Localized Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 a?? 2026’ available with Market Study Report, North America autoimmune disease diagnostics market is expected to surpass a valuation of USD 6.5 billion by the year 2026.
 

Industry experts claim that increasing adoption of laboratory automation technologies along with multiple beneficial attributes of the procedure such as better reproducibility & accuracy, lesser workload, increased turnaround time, and enhanced time-efficiency are augmenting the growth of North America autoimmune disease diagnostics market size.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2609859/
 

Moreover, favorable government initiatives towards curbing healthcare expenditure coupled with rising prevalence of autoimmune diseases, predominantly in the U.S. are further stimulating the overall market outlook. However, scarcity of skilled healthcare professionals is expected to hinder the industry growth throughout the analysis timeframe.
 

Based on product, the systematic autoimmune disease control segment of North America autoimmune disease diagnostics market was worth around USD 2 billion in the year 2019 and is anticipated to witness significant growth through 2026. Growing awareness towards disease diagnostics, rising prevalence of autoimmune diseases, favorable government initiatives including awareness campaigns, and technological advancements such as autoantibody screening tests are fueling the growth of the segment.
 

As per the country-level analysis, the report states that U.S. accounted for majority share in North America autoimmune disease diagnostics market in 2019 and is predicted to expand considerably during the forecast period.
 

Alternatively, Canada autoimmune disease diagnostics market is projected to register a CAGR of 1.9% over 2020-2026. Increasing healthcare expenditure, growing prevalence of autoimmune diseases, and rising number of research and development activities are fueling the growth of autoimmune disease diagnostics market size in Canada.
 

The leading organizations that define the North America autoimmune disease diagnostics market trends are Crescendo Bioscience, Inc., Siemens Healthineers AG, F. Hoffmann-La Roche AG, SQI Diagnostics Inc., Quest Diagnostics, Inova Diagnostics, Inc., Hemagen Diagnostics, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., and Abbott Laboratories.